Through the partnership, UMC Utrecht will use Paige’s suite of AI prostate health tools, and clinicians will report on the efficiency of diagnoses provided by these AI tools, according to a Nov. 16 Paige news release.
In addition to prostate cancer detection, UMC Utrecht will evaluate Paige’s AI tool that aims to detect if breast cancer has metastasized to lymph nodes.
“UMC Utrecht and Paige share a vision to improve outcomes for patients with cancer and health systems by leveraging quality AI solutions that help standardize the cancer diagnosis process,” Paige CEO Andy Moye, PhD, said. “Specifically, this collaboration builds on pioneering work from Utrecht which demonstrated large systemic variability in Gleason scoring of prostate biopsies nationwide in the Netherlands. Paige’s AI software can help overcome these diagnostic challenges. This partnership marks another significant milestone in our efforts to modernize and improve the process of cancer diagnosis globally.”
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
